Pharma Sector: Few Newsmakers Of The Week - Pharmaxis, Celgene ...
Trading Markets - Los Angeles,CA,USA
Last month, Opexa reported positive results from an early stage dose escalation clinical trial of Tovaxin. In the one-year, 10-subject Phase I/II clinical ...
See all stories on this topic

Jacobs receives contract for biotechnology project in Denmark
Construction and Maintenance News - Minsk,Belarus
The manufacturing facility is expected to produce TYSABRI (natalizumab), which is used in the treatment of multiple sclerosis. Officials did not disclose ...
See all stories on this topic